191 related articles for article (PubMed ID: 9773751)
1. Early preprandial hypoglycemia after administration of insulin lispro.
Iafusco D; Angius E; Prisco F
Diabetes Care; 1998 Oct; 21(10):1777-8. PubMed ID: 9773751
[No Abstract] [Full Text] [Related]
2. A word of caution on the use of lispro.
Bartsocas CS
Diabetes Care; 1998 Mar; 21(3):462. PubMed ID: 9540035
[No Abstract] [Full Text] [Related]
3. Efficacy comparison between preprandial and postprandial insulin aspart administration with dose adjustment for unpredictable meal size.
Jovanovic L; Giammattei J; Acquistapace M; Bornstein K; Sommermann E; Pettitt DJ
Clin Ther; 2004 Sep; 26(9):1492-7. PubMed ID: 15531011
[TBL] [Abstract][Full Text] [Related]
4. A randomised controlled trial of insulin lispro given before or after meals in pregnant women with type 1 diabetes--the effect on glycaemic excursion.
Carr KJ; Idama TO; Masson EA; Ellis K; Lindow SW
J Obstet Gynaecol; 2004 Jun; 24(4):382-6. PubMed ID: 15203576
[TBL] [Abstract][Full Text] [Related]
5. Treatment of type 1 diabetes with insulin lispro during Ramadan.
Kadiri A; Al-Nakhi A; El-Ghazali S; Jabbar A; Al Arouj M; Akram J; Wyatt J; Assem A; Ristic S
Diabetes Metab; 2001 Sep; 27(4 Pt 1):482-6. PubMed ID: 11547222
[TBL] [Abstract][Full Text] [Related]
6. Insulin lispro: new preparation. Faster acting.
Prescrire Int; 1998 Jun; 7(35):67-8. PubMed ID: 10342918
[TBL] [Abstract][Full Text] [Related]
7. [Analog insulin requirements of the average patient. Interview by Dr. rer. nat. Anita Schweiger].
Renner MR
Fortschr Med; 1997 Apr; 115(10):8-10. PubMed ID: 9206690
[No Abstract] [Full Text] [Related]
8. Lispro or regular insulin for multiple injection therapy in adolescence. Differences in free insulin and glucose levels overnight.
Mohn A; Matyka KA; Harris DA; Ross KM; Edge JA; Dunger DB
Diabetes Care; 1999 Jan; 22(1):27-32. PubMed ID: 10333899
[TBL] [Abstract][Full Text] [Related]
9. Selecting an insulin program for type 1 diabetes.
Scheiner G
Diabetes Self Manag; 2003; 20(5):54-6, 58. PubMed ID: 14679953
[No Abstract] [Full Text] [Related]
10. Twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn therapy for newly diagnosed type 1 diabetes.
Al Shamsi AM
Pediatrics; 2008 Sep; 122(3):675-6; author reply 676. PubMed ID: 18762540
[No Abstract] [Full Text] [Related]
11. Parental preference of prandial insulin aspart compared with preprandial human insulin in a basal-bolus scheme with NPH insulin in a 12-wk crossover study of preschool children with type 1 diabetes.
Danne T; Råstam J; Odendahl R; Näke A; Schimmel U; Szczepanski R; Moeller J; Deiss D
Pediatr Diabetes; 2007 Oct; 8(5):278-85. PubMed ID: 17850471
[TBL] [Abstract][Full Text] [Related]
12. A case of hypoglycemic brittle diabetes with peripheral edema successfully managed by conversion from insulin lispro to insulin aspart.
Tone A; Shikata K; Nakagawa K; Hashimoto M; Makino H
Diabetes Res Clin Pract; 2008 Sep; 81(3):e15-6. PubMed ID: 18676048
[No Abstract] [Full Text] [Related]
13. A comparative study of insulin lispro and human regular insulin in patients with type 2 diabetes mellitus and secondary failure of oral hypoglycemic agents.
Ross SA; Zinman B; Campos RV; Strack T;
Clin Invest Med; 2001 Dec; 24(6):292-8. PubMed ID: 11767232
[TBL] [Abstract][Full Text] [Related]
14. Postprandial rather than preprandial glucose levels should be used for adjustment of rapid-acting insulins.
Bell DS; Ovalle F; Shadmany S
Endocr Pract; 2000; 6(6):477-8. PubMed ID: 11155223
[No Abstract] [Full Text] [Related]
15. Pharmacokinetics and pharmacodynamics of the long-acting insulin analog glargine after 1 week of use compared with its first administration in subjects with type 1 diabetes.
Porcellati F; Rossetti P; Ricci NB; Pampanelli S; Torlone E; Campos SH; Andreoli AM; Bolli GB; Fanelli CG
Diabetes Care; 2007 May; 30(5):1261-3. PubMed ID: 17303785
[No Abstract] [Full Text] [Related]
16. Preprandial combination of lispro and NPH insulin improves overall blood glucose control in type 1 diabetic patients: a multicenter randomized crossover trial.
Annuzzi G; Del Prato S; Arcari R; Bellomo Damato A; Benzi L; Bruttomesso D; Calderini MC; Coscelli C; Fedele D; Galluzzo A; Giordano M; Giorgino R; Lapolla A; Orsini P; Pagano G; Santoro D; Riccardi G
Nutr Metab Cardiovasc Dis; 2001 Jun; 11(3):168-75. PubMed ID: 11590992
[TBL] [Abstract][Full Text] [Related]
17. Semi-closed-loop insulin delivery systems: early experience with low-glucose insulin suspend pumps.
Pickup JC
Diabetes Technol Ther; 2011 Jul; 13(7):695-8. PubMed ID: 21668344
[No Abstract] [Full Text] [Related]
18. Glucose profiles in a type 1 diabetic patient successively treated with CSII using regular insulin, lispro and an implantable insulin pump.
Catargi B; Breilh D; Roger P; Tabarin A
Diabetes Metab; 2000 May; 26(3):210-4. PubMed ID: 10880895
[TBL] [Abstract][Full Text] [Related]
19. [Insulin treatment of type 1 diabetes in adults].
Birkeland KI
Tidsskr Nor Laegeforen; 2006 Mar; 126(6):776-8. PubMed ID: 16541173
[No Abstract] [Full Text] [Related]
20. [Optimum time of insulin therapy in type I diabetes mellitus].
Vílchez Joya R; Miguel B; Sánchez-Cantalejo E; Luna J; Corpas MS
Med Clin (Barc); 1986 Jul; 87(6):228-30. PubMed ID: 3526020
[No Abstract] [Full Text] [Related]
[Next] [New Search]
